T細胞淋巴瘤的全球市場 2022-2026

T細胞淋巴瘤的市場規模，預計從2022年～2026年之間以8.21％的年複合成長率成長7億6807萬美元。

本報告提供T細胞淋巴瘤市場整體分析，市場規模與預測，趨勢，成長促進因素、課題，網羅了約25供應商的供應商分析等資訊。

提供目前全球市場趨勢與推動因素、市場整體環境的最新分析。由於老年人口增加，對復發或難治性的T細胞淋巴瘤患者的治療藥的認證增加，T細胞淋巴瘤的發生率增加，牽引市場。

目錄

第1章 摘要整理

• 市場概要

第2章 市場形勢

• 市場生態系統

第3章 市場規模

• 市場定義
• 市場區隔分析
• 市場規模 2021
• 市場預測:2021-2026年的預測

第4章 波特的五力分析

• 五力的摘要
• 買方議價能力
• 供給企業談判力
• 新加入業者的威脅
• 替代品的威脅
• 競爭的威脅
• 市場情況

第5章 各類型的市場區隔

• 市場明細
• 各類型比較
• 末梢性T細胞淋巴瘤 - 市場規模與預測 2021-2026
• T細胞淋巴芽球性淋巴瘤 - 市場規模與預測 2021-2026
• 各類型的市場機會

第6章 客戶形勢

• 客戶形勢概要

第7章 各地區形勢

• 各地區市場區隔
• 各地區比較
• 北美 - 市場規模與預測 2021-2026
• 歐洲 - 市場規模與預測 2021-2026
• 亞洲 - 市場規模與預測 2021-2026
• 其他地區(ROW) - 市場規模與預測 2021-2026
• 美國 - 市場規模與預測 2021-2026
• 德國 - 市場規模與預測 2021-2026
• 英國 - 市場規模與預測 2021-2026
• 加拿大 - 市場規模與預測 2021-2026
• 中國 - 市場規模與預測 2021-2026
• 各地區形勢的市場機會

第8章 原動力，課題，及趨勢

• 推動市場要素
• 市場課題
• 推動要素與課題的影響
• 市場趨勢

第9章 業者情勢

• 概要
• 業者情勢
• 混亂狀況
• 產業的風險

第10章 供應商分析

• 交易廠商
• 供應商的市場定位
• AbbVie Inc.
• AstraZeneca Plc
• Biogen Inc.
• Bristol Myers Squibb Co.
• F. Hoffmann La Roche Ltd.
• GSK Plc
• Johnson and Johnson
• Merck and Co. Inc.
• Novartis AG
• Pfizer Inc.

第11章 附錄

Technavio has been monitoring the T-cell lymphoma market and it is poised to grow by $ 768.07 mn during 2022-2026, accelerating at a CAGR of 8.21% during the forecast period. Our report on the T-cell lymphoma market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the growing geriatric population, increasing approval of therapeutics for patients with relapsed or refractory T-cell lymphoma, and increasing incidence of T-cell lymphoma.

The T-cell lymphoma market analysis includes the type segment and geographic landscape.

Technavio's T-cell lymphoma market is segmented as below:

By Type

• Peripheral T-cell lymphomas
• T-cell lymphoblastic lymphoma

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies technological advancements as one of the prime reasons driving the T-cell lymphoma market growth during the next few years. Also, increasing patient support programs and strategic alliances will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the T-cell lymphoma market covers the following areas:

• T-cell lymphoma market sizing
• T-cell lymphoma market forecast
• T-cell lymphoma market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading T-cell lymphoma market vendors that include AbbVie Inc., Accredo Health Group Inc., AstraZeneca Plc, Autolus Therapeutics Plc, Baxter International Inc., Biogen Inc., Bristol Myers Squibb Co., Eli Lilly and Co., F. Hoffmann La Roche Ltd., Genmab AS, GSK Plc, H. Lee Moffitt Cancer Center and Research Institute Inc., Johnson and Johnson, Macopharma SA, Merck and Co. Inc., Mundipharma International Ltd., Novartis AG, Pfizer Inc., Sanofi, Teva Pharmaceutical Industries Ltd., and TYME Inc. Also, the T-cell lymphoma market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
• Exhibit 06: Executive Summary - Chart on Incremental Growth
• Exhibit 07: Executive Summary - Data Table on Incremental Growth
• Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 09: Parent market
• Exhibit 10: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 11: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 12: Market segments
• 3.3 Market size 2021
• 3.4 Market outlook: Forecast for 2021-2026
• Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

• 4.1 Five forces summary
• Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
• 4.2 Bargaining power of buyers
• Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
• 4.3 Bargaining power of suppliers
• Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
• 4.4 Threat of new entrants
• Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
• 4.5 Threat of substitutes
• Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
• 4.6 Threat of rivalry
• Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
• 4.7 Market condition
• Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Type

• 5.1 Market segments
• Exhibit 24: Chart on Type - Market share 2021-2026 (%)
• Exhibit 25: Data Table on Type - Market share 2021-2026 (%)
• 5.2 Comparison by Type
• Exhibit 26: Chart on Comparison by Type
• Exhibit 27: Data Table on Comparison by Type
• 5.3 Peripheral T-cell lymphomas - Market size and forecast 2021-2026
• Exhibit 28: Chart on Peripheral T-cell lymphomas - Market size and forecast 2021-2026 ($ million)
• Exhibit 29: Data Table on Peripheral T-cell lymphomas - Market size and forecast 2021-2026 ($ million)
• Exhibit 30: Chart on Peripheral T-cell lymphomas - Year-over-year growth 2021-2026 (%)
• Exhibit 31: Data Table on Peripheral T-cell lymphomas - Year-over-year growth 2021-2026 (%)
• 5.4 T-cell lymphoblastic lymphoma - Market size and forecast 2021-2026
• Exhibit 32: Chart on T-cell lymphoblastic lymphoma - Market size and forecast 2021-2026 ($ million)
• Exhibit 33: Data Table on T-cell lymphoblastic lymphoma - Market size and forecast 2021-2026 ($ million)
• Exhibit 34: Chart on T-cell lymphoblastic lymphoma - Year-over-year growth 2021-2026 (%)
• Exhibit 35: Data Table on T-cell lymphoblastic lymphoma - Year-over-year growth 2021-2026 (%)
• 5.5 Market opportunity by Type
• Exhibit 36: Market opportunity by Type ($ million)

6 Customer Landscape

• 6.1 Customer landscape overview
• Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

• 7.1 Geographic segmentation
• Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
• Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
• 7.2 Geographic comparison
• Exhibit 40: Chart on Geographic comparison
• Exhibit 41: Data Table on Geographic comparison
• 7.3 North America - Market size and forecast 2021-2026
• Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
• Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
• 7.4 Europe - Market size and forecast 2021-2026
• Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
• Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
• 7.5 Asia - Market size and forecast 2021-2026
• Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
• Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
• 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
• Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• 7.7 US - Market size and forecast 2021-2026
• Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
• Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
• 7.8 Germany - Market size and forecast 2021-2026
• Exhibit 62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibit 63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibit 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
• Exhibit 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
• 7.9 UK - Market size and forecast 2021-2026
• Exhibit 66: Chart on UK - Market size and forecast 2021-2026 ($ million)
• Exhibit 67: Data Table on UK - Market size and forecast 2021-2026 ($ million)
• Exhibit 68: Chart on UK - Year-over-year growth 2021-2026 (%)
• Exhibit 69: Data Table on UK - Year-over-year growth 2021-2026 (%)
• 7.10 Canada - Market size and forecast 2021-2026
• Exhibit 70: Chart on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibit 71: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibit 72: Chart on Canada - Year-over-year growth 2021-2026 (%)
• Exhibit 73: Data Table on Canada - Year-over-year growth 2021-2026 (%)
• 7.11 China - Market size and forecast 2021-2026
• Exhibit 74: Chart on China - Market size and forecast 2021-2026 ($ million)
• Exhibit 75: Data Table on China - Market size and forecast 2021-2026 ($ million)
• Exhibit 76: Chart on China - Year-over-year growth 2021-2026 (%)
• Exhibit 77: Data Table on China - Year-over-year growth 2021-2026 (%)
• 7.12 Market opportunity By Geographical Landscape
• Exhibit 78: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends

• 8.1 Market drivers
• 8.2 Market challenges
• 8.3 Impact of drivers and challenges
• Exhibit 79: Impact of drivers and challenges in 2021 and 2026
• 8.4 Market trends

9 Vendor Landscape

• 9.1 Overview
• 9.2 Vendor landscape
• Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
• 9.3 Landscape disruption
• Exhibit 81: Overview on factors of disruption
• 9.4 Industry risks
• Exhibit 82: Impact of key risks on business

10 Vendor Analysis

• 10.1 Vendors covered
• Exhibit 83: Vendors covered
• 10.2 Market positioning of vendors
• Exhibit 84: Matrix on vendor position and classification
• 10.3 AbbVie Inc.
• Exhibit 85: AbbVie Inc. - Overview
• Exhibit 86: AbbVie Inc. - Product / Service
• Exhibit 87: AbbVie Inc. - Key offerings
• 10.4 AstraZeneca Plc
• Exhibit 88: AstraZeneca Plc - Overview
• Exhibit 89: AstraZeneca Plc - Product / Service
• Exhibit 90: AstraZeneca Plc - Key news
• Exhibit 91: AstraZeneca Plc - Key offerings
• 10.5 Biogen Inc.
• Exhibit 92: Biogen Inc. - Overview
• Exhibit 93: Biogen Inc. - Product / Service
• Exhibit 94: Biogen Inc. - Key offerings
• 10.6 Bristol Myers Squibb Co.
• Exhibit 95: Bristol Myers Squibb Co. - Overview
• Exhibit 96: Bristol Myers Squibb Co. - Product / Service
• Exhibit 97: Bristol Myers Squibb Co. - Key offerings
• 10.7 F. Hoffmann La Roche Ltd.
• Exhibit 98: F. Hoffmann La Roche Ltd. - Overview
• Exhibit 99: F. Hoffmann La Roche Ltd. - Business segments
• Exhibit 100: F. Hoffmann La Roche Ltd. - Key news
• Exhibit 101: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibit 102: F. Hoffmann La Roche Ltd. - Segment focus
• 10.8 GSK Plc
• Exhibit 103: GSK Plc - Overview
• Exhibit 104: GSK Plc - Business segments
• Exhibit 105: GSK Plc - Key news
• Exhibit 106: GSK Plc - Key offerings
• Exhibit 107: GSK Plc - Segment focus
• 10.9 Johnson and Johnson
• Exhibit 108: Johnson and Johnson - Overview
• Exhibit 109: Johnson and Johnson - Business segments
• Exhibit 110: Johnson and Johnson - Key news
• Exhibit 111: Johnson and Johnson - Key offerings
• Exhibit 112: Johnson and Johnson - Segment focus
• 10.10 Merck and Co. Inc.
• Exhibit 113: Merck and Co. Inc. - Overview
• Exhibit 114: Merck and Co. Inc. - Business segments
• Exhibit 115: Merck and Co. Inc. - Key news
• Exhibit 116: Merck and Co. Inc. - Key offerings
• Exhibit 117: Merck and Co. Inc. - Segment focus
• 10.11 Novartis AG
• Exhibit 118: Novartis AG - Overview
• Exhibit 119: Novartis AG - Business segments
• Exhibit 120: Novartis AG - Key offerings
• Exhibit 121: Novartis AG - Segment focus
• 10.12 Pfizer Inc.
• Exhibit 122: Pfizer Inc. - Overview
• Exhibit 123: Pfizer Inc. - Product / Service
• Exhibit 124: Pfizer Inc. - Key news
• Exhibit 125: Pfizer Inc. - Key offerings

11 Appendix

• 11.1 Scope of the report
• 11.2 Inclusions and exclusions checklist
• Exhibit 126: Inclusions checklist
• Exhibit 127: Exclusions checklist
• 11.3 Currency conversion rates for US$
• Exhibit 128: Currency conversion rates for US$
• 11.4 Research methodology
• Exhibit 129: Research methodology
• Exhibit 130: Validation techniques employed for market sizing
• Exhibit 131: Information sources
• 11.5 List of abbreviations
• Exhibit 132: List of abbreviations

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Type
• Exhibits6: Executive Summary - Chart on Incremental Growth
• Exhibits7: Executive Summary - Data Table on Incremental Growth
• Exhibits8: Executive Summary - Chart on Vendor Market Positioning
• Exhibits9: Parent market
• Exhibits10: Market Characteristics
• Exhibits11: Offerings of vendors included in the market definition
• Exhibits12: Market segments
• Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
• Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
• Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibits17: Five forces analysis - Comparison between 2021 and 2026
• Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
• Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
• Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
• Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
• Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
• Exhibits23: Chart on Market condition - Five forces 2021 and 2026
• Exhibits24: Chart on Type - Market share 2021-2026 (%)
• Exhibits25: Data Table on Type - Market share 2021-2026 (%)
• Exhibits26: Chart on Comparison by Type
• Exhibits27: Data Table on Comparison by Type
• Exhibits28: Chart on Peripheral T-cell lymphomas - Market size and forecast 2021-2026 ($ million)
• Exhibits29: Data Table on Peripheral T-cell lymphomas - Market size and forecast 2021-2026 ($ million)
• Exhibits30: Chart on Peripheral T-cell lymphomas - Year-over-year growth 2021-2026 (%)
• Exhibits31: Data Table on Peripheral T-cell lymphomas - Year-over-year growth 2021-2026 (%)
• Exhibits32: Chart on T-cell lymphoblastic lymphoma - Market size and forecast 2021-2026 ($ million)
• Exhibits33: Data Table on T-cell lymphoblastic lymphoma - Market size and forecast 2021-2026 ($ million)
• Exhibits34: Chart on T-cell lymphoblastic lymphoma - Year-over-year growth 2021-2026 (%)
• Exhibits35: Data Table on T-cell lymphoblastic lymphoma - Year-over-year growth 2021-2026 (%)
• Exhibits36: Market opportunity by Type ($ million)
• Exhibits37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits38: Chart on Market share By Geographical Landscape 2021-2026 (%)
• Exhibits39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
• Exhibits40: Chart on Geographic comparison
• Exhibits41: Data Table on Geographic comparison
• Exhibits42: Chart on North America - Market size and forecast 2021-2026 ($ million)
• Exhibits43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
• Exhibits44: Chart on North America - Year-over-year growth 2021-2026 (%)
• Exhibits45: Data Table on North America - Year-over-year growth 2021-2026 (%)
• Exhibits46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibits47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibits48: Chart on Europe - Year-over-year growth 2021-2026 (%)
• Exhibits49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
• Exhibits50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibits51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibits52: Chart on Asia - Year-over-year growth 2021-2026 (%)
• Exhibits53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
• Exhibits54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibits55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibits56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibits57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibits58: Chart on US - Market size and forecast 2021-2026 ($ million)
• Exhibits59: Data Table on US - Market size and forecast 2021-2026 ($ million)
• Exhibits60: Chart on US - Year-over-year growth 2021-2026 (%)
• Exhibits61: Data Table on US - Year-over-year growth 2021-2026 (%)
• Exhibits62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibits63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibits64: Chart on Germany - Year-over-year growth 2021-2026 (%)
• Exhibits65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
• Exhibits66: Chart on UK - Market size and forecast 2021-2026 ($ million)
• Exhibits67: Data Table on UK - Market size and forecast 2021-2026 ($ million)
• Exhibits68: Chart on UK - Year-over-year growth 2021-2026 (%)
• Exhibits69: Data Table on UK - Year-over-year growth 2021-2026 (%)
• Exhibits70: Chart on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibits71: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibits72: Chart on Canada - Year-over-year growth 2021-2026 (%)
• Exhibits73: Data Table on Canada - Year-over-year growth 2021-2026 (%)
• Exhibits74: Chart on China - Market size and forecast 2021-2026 ($ million)
• Exhibits75: Data Table on China - Market size and forecast 2021-2026 ($ million)
• Exhibits76: Chart on China - Year-over-year growth 2021-2026 (%)
• Exhibits77: Data Table on China - Year-over-year growth 2021-2026 (%)
• Exhibits78: Market opportunity By Geographical Landscape ($ million)
• Exhibits79: Impact of drivers and challenges in 2021 and 2026
• Exhibits80: Overview on Criticality of inputs and Factors of differentiation
• Exhibits81: Overview on factors of disruption
• Exhibits82: Impact of key risks on business
• Exhibits83: Vendors covered
• Exhibits84: Matrix on vendor position and classification
• Exhibits85: AbbVie Inc. - Overview
• Exhibits86: AbbVie Inc. - Product / Service
• Exhibits87: AbbVie Inc. - Key offerings
• Exhibits88: AstraZeneca Plc - Overview
• Exhibits89: AstraZeneca Plc - Product / Service
• Exhibits90: AstraZeneca Plc - Key news
• Exhibits91: AstraZeneca Plc - Key offerings
• Exhibits92: Biogen Inc. - Overview
• Exhibits93: Biogen Inc. - Product / Service
• Exhibits94: Biogen Inc. - Key offerings
• Exhibits95: Bristol Myers Squibb Co. - Overview
• Exhibits96: Bristol Myers Squibb Co. - Product / Service
• Exhibits97: Bristol Myers Squibb Co. - Key offerings
• Exhibits98: F. Hoffmann La Roche Ltd. - Overview
• Exhibits99: F. Hoffmann La Roche Ltd. - Business segments
• Exhibits100: F. Hoffmann La Roche Ltd. - Key news
• Exhibits101: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibits102: F. Hoffmann La Roche Ltd. - Segment focus
• Exhibits103: GSK Plc - Overview
• Exhibits104: GSK Plc - Business segments
• Exhibits105: GSK Plc - Key news
• Exhibits106: GSK Plc - Key offerings
• Exhibits107: GSK Plc - Segment focus
• Exhibits108: Johnson and Johnson - Overview
• Exhibits109: Johnson and Johnson - Business segments
• Exhibits110: Johnson and Johnson - Key news
• Exhibits111: Johnson and Johnson - Key offerings
• Exhibits112: Johnson and Johnson - Segment focus
• Exhibits113: Merck and Co. Inc. - Overview
• Exhibits114: Merck and Co. Inc. - Business segments
• Exhibits115: Merck and Co. Inc. - Key news
• Exhibits116: Merck and Co. Inc. - Key offerings
• Exhibits117: Merck and Co. Inc. - Segment focus
• Exhibits118: Novartis AG - Overview
• Exhibits119: Novartis AG - Business segments
• Exhibits120: Novartis AG - Key offerings
• Exhibits121: Novartis AG - Segment focus
• Exhibits122: Pfizer Inc. - Overview
• Exhibits123: Pfizer Inc. - Product / Service
• Exhibits124: Pfizer Inc. - Key news
• Exhibits125: Pfizer Inc. - Key offerings
• Exhibits126: Inclusions checklist
• Exhibits127: Exclusions checklist
• Exhibits128: Currency conversion rates for US$
• Exhibits129: Research methodology
• Exhibits130: Validation techniques employed for market sizing
• Exhibits131: Information sources
• Exhibits132: List of abbreviations